Related Experiment Video
Updated: Jan 20, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
Heather Torbic1, Sudhir Krishnan2, Abhijit Duggal2
1Department of Pharmacy, Cleveland Clinic, 9500 Euclid Avenue, Hb-105, Cleveland, OH, 44195, USA. torbich@ccf.org.
No abstract available in PubMed .
Related Concept Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
06:06Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
07:20Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome (ARDS)
04:45Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
08:22The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit

